Please login to the form below

Not currently logged in
Email:
Password:

Retroviruses found in chronic fatigue cases

In a recent study, almost 90 per cent of CFS patients showed signs of infection with a group of mouse leukaemia viruses

In a recent study, almost 90 per cent of patients with chronic fatigue syndrome (CFS) showed signs of infection with retroviruses, suggesting that antiviral drugs could be used to treat the disease.

In the US government study, researchers identified at least one of four different murine-related leukaemia viruses in 86.5 per cent of the 37 patients with CFS compared to 6.8 per cent of 44 patients without the disease.

The results suggest antiviral drugs including Merck's Isentress (raltegravir) and Gilead Science's Viread (tenofovir) should be tested for the condition.

The study published in the Proceedings of the National Academy of Sciences, supports findings from last year that linked CFS to a related infectious agent, called XMRV. But they are contrary to last month's report from the US Centers for Disease Control and Prevention that failed to find a viral link.

Murine-related leukaemia is a form of an infectious agent known to cause leukaemia and other cancers in mice. Whether it causes diseases in humans is not known.

CFS affects around 17 million people worldwide.

24th August 2010

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
11 London

The biggest problems facing humanity today are health-related, and the health of people, animals and our planet are inextricably linked. ...

Latest intelligence

How can we strike the right balance between familiarity and innovation when it comes to data presentation?
Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...
Deep 6 AI: the smart software breathing new life into clinical trials
Fishawack Health interviews Wout Brusselaers, the Deep 6 AI CEO using artificial intelligence to solve one of the greatest barriers stagnating healthcare innovation—clinical trial recruitment and retention....
COVID-proof: How Teams are Creating Launch Intensity thru Adversity
Now that the game has changed, how are marketers shifting their launch behaviour? We've identified 5 common observations from effective teams....